A bipartisan group of senators Aug. 5 introduced the Supporting Underserved and Strengthening Transparency, Accountability ...

Known as 340B, the program has helped Virginia hospitals and clinics and others nationwide care for underserved patients by ...

The transition to the CVS CostVantage model is intended to stabilize pharmacy reimbursement and align more closely with payer value, though it requires careful execution. Aetna's exit from the ...

After years of bipartisan deliberation, U.S. Sen. Tim Kaine, D-Va., has introduced legislation to strengthen and protect a ...

CVS Health saw its shares dip about 6% even though it handily beat Wall Street’s expectations for the most recent quarter and raised its guidance for 2026 earnings. The issue was the company’s ...

The Central Government has tightened oversight of GLP-1 medicines to curb misleading promotions and ensure their use only ...

Novo’s Wegovy pill thesis continues to bear out in 2026, as the oral obesity med keeps impressive sales apace while sparing ...

Amgen beats Q2 earnings and revenue estimates and lifts its 2026 outlook. Key products witness strong growth despite ...

Q1 FY2027 earnings call: raised EPS guide to $44.20–$45.00, strong revenue, GLP-1 trends, Wellverse spinoff—read now.

CVS Health posts better-than-expected second-quarter earnings and raises its full-year outlook.

Pet owners can fill select medications for dogs and cats at CVS Pharmacy stores, with delivery, automatic refills and other services available. Three major hospital systems have accused CVS of ...